KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Gains from Investment Securities (2016 - 2025)

Rigel Pharmaceuticals has reported Gains from Investment Securities over the past 16 years, most recently at $1.4 million for Q3 2025.

  • For Q3 2025, Gains from Investment Securities fell 7.39% year-over-year to $1.4 million; the TTM value through Sep 2025 reached $1.4 million, down 7.39%, while the annual FY2025 figure was $1.1 million, 70.18% down from the prior year.
  • Gains from Investment Securities for Q3 2025 was $1.4 million at Rigel Pharmaceuticals, up from $1.4 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $13.1 million in Q3 2023 and troughed at -$510000.0 in Q1 2022.
  • A 5-year average of $5.1 million and a median of $1.5 million in 2024 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: crashed 105.26% in 2022 and later surged 7374.65% in 2024.
  • Year by year, Gains from Investment Securities stood at $39000.0 in 2021, then surged by 1669.23% to $690000.0 in 2022, then tumbled by 87.68% to $85000.0 in 2023, then surged by 4093.79% to $3.6 million in 2024, then crashed by 60.5% to $1.4 million in 2025.
  • Business Quant data shows Gains from Investment Securities for RIGL at $1.4 million in Q3 2025, $1.4 million in Q2 2025, and $605514.0 in Q1 2025.